scroll to top
0

EBSCO Auth Banner

Let's find your institution. Click here.

Advanced Search Results For "Delfraissy JF"

1 - 10 of 397 results for
 "Delfraissy JF"
Results per page:

Safety and immunogenicity of a monovalent 2009 influenza A/H1N1v vaccine adjuvanted with AS03A or unadjuvanted in HIV-infected adults: a randomized, controlled trial.

Publication Type: Academic Journal

Source(s): Journal of Infectious Diseases; 2011, Vol. 204 Issue 1, p124-134, 11p

Abstract: Copyright of Journal of Infectious Diseases is the property of Oxford University Press / USA and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, user...

Impact of Newly Available Drugs on Clinical Progression in Patients with Virological Failure after Exposure to Three Classes of Antiretrovirals

Publication Type: Periodical

Source(s): Antiviral Therapy; May 2005, Vol. 10 Issue: 4 p563-573, 11p

Abstract: Objective To study the prognosis of HIV-infected patients with virological failure after exposure to three classes of antiretroviral drugs (ARVs).Design Cohort study. Setting: French Hospital Database on HIV.Patients Patients previously exposed to a...

Triple Nucleoside Combination Zidovudine/Lamivudine/Abacavir versus Zidovudine/Lamivudine/Nelfinavir as First-Line Therapy in HIV-1-Infected Adults: A Randomized Trial

Publication Type: Periodical

Source(s): Antiviral Therapy; February 2003, Vol. 8 Issue: 2 p163-171, 9p

Abstract: Objective To compare the efficacy and safety of a triple nucleoside combination to a protease inhibitor-containing triple regimen as first-line antiretroviral therapy (ART) in HIV-1-infected patients.Design Open-label study in HIV-1-infected ART-naiv...

Development of resistance mutations in women receiving standard antiretroviral therapy who received intrapartum nevirapine to prevent perinatal human immunodeficiency virus type 1 transmission: a substudy of Pediatric AIDS Clinical Trials Group protocol 316.

Publication Type: Academic Journal

Source(s): Journal of Infectious Diseases; 7/15/2002, Vol. 186 Issue 2, p181-188, 8p

Abstract: Copyright of Journal of Infectious Diseases is the property of Oxford University Press / USA and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, user...

Five-Year Follow up of Once-Daily Therapy with Emtricitabine, Didanosine and Efavirenz (Montana ANRS 091 Trial)

Publication Type: Periodical

Source(s): Antiviral Therapy; April 2007, Vol. 12 Issue: 3 p417-422, 6p

Abstract: Background Once-daily combination therapy with emtricitabine, didanosine and efavirenz has been highly effective in clinical trials but its long-term efficacy and safety has not been previously reported.Methods This multicentre, single-arm, open-labe...

Salvage Therapy with Amprenavir, Lopinavir and Ritonavir 200 Mg/D or 400 Mg/D in HIV-Infected Patients in Virological Failure

Publication Type: Periodical

Source(s): Antiviral Therapy; May 2004, Vol. 9 Issue: 4 p615-625, 11p

Abstract: Objectives To compare the antiviral efficacy of a salvage therapy combining lopinavir and amprenavir with 200 mg/d or 400 mg/d ritonavir, together with nucleoside reverse transcriptase inhibitors, over a 26-week period in HIV-infected patients in whom...

Bénéfice des inhibiteurs de protéase dans les thrombopénies sévères liées au VIH

Publication Type: Periodical

Source(s): La Revue de Médecine Interne; June 1998, Vol. 19 p167S-167S, 1p

[French research organization on emerging infectious diseases: from REACTing to ANRS Emerging Infectious Diseases].

Publication Type: Academic Journal

Source(s): Bulletin de l'Academie nationale de medecine [Bull Acad Natl Med] 2023 Jan 18. Date of Electronic Publication: 2023 Jan 18.

Authors:

Abstract: Emerging nfectious diseases (EIDs) can be responsible for epidemics or even pandemics that disrupt societies and cause national and international crises. In our globalized world, anarchic urbanization, ecosystem disruptions (deforestation, creation of ...

After 2 years of the COVID-19 pandemic, translating One Health into action is urgent.

Publication Type: Academic Journal

Source(s): Lancet (London, England) [Lancet] 2022 Oct 21. Date of Electronic Publication: 2022 Oct 21.

Abstract: Competing Interests: Declaration of interests All authors are members of the French COVID-19 Scientific Council. J-FD is the President of the Council.

sponsored